10.1007/s00018-024-05507-6 25 DanpanichkulP.SuparanK.DiazL
A 2024 animal study published in Biochemical and Biophysical Research Communications found that semaglutide suppressed bone formation markers and increased bone resorption in female mice (ScienceDirect, 2024)
Using our proprietary Fc-fusion protein platform, we develop immuno-enhancing and targeted protein treatments that aim to reduce treatment frequency while enhancing efficacy
Westman EC, Yancy WS Jr, Mavropoulos JC, Marquart M, McDuffie JR
Industry insights Article Balancing the risks and the benefits of GLP-1 drugs
However, at least one study has suggested that adult humans are unlikely to see clinically significant changes, while children and adolescents using Lepraxo may experience slower growth and weight gain